4.3 Letter

The case for reduced-dose metformin in the management of type 2 diabetes mellitus with stage 4 chronic kidney disease

Journal

DIABETIC MEDICINE
Volume 39, Issue 10, Pages -

Publisher

WILEY
DOI: 10.1111/dme.14932

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available